ICU Medical Inc (ICUI)

Pretax margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Earnings before tax but after interest (EBT) (ttm)	US$ in thousands	-66,012	-110,910	-98,348	-101,678	-78,299	-63,065	-79,006	-72,997	-114,409	-69,625	-10,393	41,293	123,186	129,958	118,199	104,205	97,494	88,306	94,890	101,658
Revenue (ttm)	US$ in thousands	2,381,346	2,339,530	2,303,710	2,256,565	2,259,259	2,249,284	2,293,830	2,305,524	2,279,997	2,042,508	1,780,711	1,541,384	1,316,308	1,296,234	1,278,741	1,260,443	1,271,004	1,266,076	1,254,980	1,263,883
Pretax margin		-2.77%	-4.74%	-4.27%	-4.51%	-3.47%	-2.80%	-3.44%	-3.17%	-5.02%	-3.41%	-0.58%	2.68%	9.36%	10.03%	9.24%	8.27%	7.67%	6.97%	7.56%	8.04%

December 31, 2024 calculation

Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $-66,012K ÷ $2,381,346K
= -2.77%

ICU Medical Inc's pretax margin has shown a declining trend over the past few quarters. At the end of December 2024, the pretax margin stood at -2.77%, marking an improvement from the previous two quarters where the margins were significantly negative. However, it is important to note that the company's profitability is still below the breakeven point.

The downward trend in pretax margin from March 2022 to December 2024 indicates that ICU Medical Inc has been facing challenges in generating profits before accounting for taxes and interest expenses. The company may need to closely monitor its cost structure, revenue generation, and overall efficiency to improve its financial performance and return to positive pretax margins.

Investors and stakeholders should pay attention to future financial reports to assess whether ICU Medical Inc can reverse this negative trend and enhance its profitability through strategic measures and operational improvements.